Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.
- DOI
- 10.3390/ijms27167503
- Published
- 2026 Aug 21
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms27167503,
title = {Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.},
author = {González-Salvatierra S and García-Fontana B and García-Fontana C and Martínez-Heredia L and Rojas-Pérez JF and Andreo-López MC and García-Martín A and Muñoz-Torres M},
year = {2026},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms27167503},
url = {https://doi.org/10.3390/ijms27167503}
}RIS
TY - JOUR TI - Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale. AU - González-Salvatierra S AU - García-Fontana B AU - García-Fontana C AU - Martínez-Heredia L AU - Rojas-Pérez JF AU - Andreo-López MC AU - García-Martín A AU - Muñoz-Torres M PY - 2026 JO - International journal of molecular sciences DO - 10.3390/ijms27167503 UR - https://doi.org/10.3390/ijms27167503 ER -
APA
S, G., B, G., C, G., L, M., JF, R., MC, A., A, G., & M, M. (2026). Serum Periostin as a Complementary Biomarker of Frailty in Type 2 Diabetes: A Pilot Study Using the FRAIL Scale.. International journal of molecular sciences. https://doi.org/10.3390/ijms27167503
Source records
- pubmed · retrieved 2026-09-25T21:38:04.292Z